dihexa renal toxicity study Effect of Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single‐Dose Phase 1 - Mittur - 2026 - Clinical Pharmacology in Drug Development Dihexa | 1401708-83-5 | BGC70883
Dihexa 1401708 83 5 BGC70883 Biosynth Effects of renal impairment on the pharmacokinetics, safety, and tolerability of pudexacianinium (ASP5354) after IV administration: a mechanistic exploration European Journal of Clinical Pharmacology Springer Nature Link Nephrotoxicity evaluation and proteomic analysis in kidneys of rats exposed to thioacetamide Scientific Reports Analysis of renal tissue after treatments. a Dihydroethidium (DHE) and Download Scientific Diagram The randomized DIALIZE Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis Kidney International Cardio renal protection and mechanisms of the antihypertensive activity of Alcalase derived moth bean hydrolysate in DOCA salt induced hypertensive Wistar rats Scientific Reports
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





